Elahere approved in EU as treatment for advanced ovarian cancer
AbbVie’s Elahere has been approved in the European Union as a treatment for adults with advanced, platinum-resistant ovarian cancer.| Rare Cancer News
I was 37 years old when my mom died. Together, we shared a lifetime of experiences: birthdays, trips, and graduations. But now, a decade after her death, the two events that linger most vividly in my mind are the moment I watched her take her last breath and the day I found out that her… The post A Family History appeared first on Resilient Sisterhood Project.| Resilient Sisterhood Project
AbbVie’s Elahere has been approved in the European Union as a treatment for adults with advanced, platinum-resistant ovarian cancer.| Rare Cancer News
Ovarian cancer tumors' microenvironment was seen to actively suppress the anti-cancer work of immune T-cells by blocking their energy supply.| Rare Cancer News
